A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis

Clinical trial NCT05303285 · RECRUITING

Trial details

NCT number: NCT05303285
Sponsor: Tongji Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Ankylosing Spondylitis (AS)

Start date: 2024-06-14
Primary completion: 2026-08-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.